Jason P. Holland - Publications

Affiliations: 
Chemistry Universität Zürich, Zürich, ZH, Switzerland 

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Cieslik PA, Klingler S, Nolff M, Holland JP. Radiolabelled 177Lu-Bispidine-Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers. Chemistry (Weinheim An Der Bergstrasse, Germany). e202303805. PMID 38064536 DOI: 10.1002/chem.202303805  0.71
2022 d'Orchymont F, Holland JP. A rotaxane-based platform for tailoring the pharmacokinetics of cancer-targeted radiotracers. Chemical Science. 13: 12713-12725. PMID 36519052 DOI: 10.1039/d2sc03928a  0.323
2022 Guillou A, Ouadi A, Holland JP. Heptadentate chelates for Zr-radiolabelling of monoclonal antibodies. Inorganic Chemistry Frontiers. 9: 3071-3081. PMID 35770072 DOI: 10.1039/d2qi00442a  0.304
2022 Earley DF, Guillou A, Klingler S, Fay R, Gut M, d'Orchymont F, Behmaneshfar S, Reichert L, Holland JP. Charting the Chemical and Mechanistic Scope of Light-Triggered Protein Ligation. Jacs Au. 2: 646-664. PMID 35373206 DOI: 10.1021/jacsau.1c00530  0.735
2022 Klingler S, Holland JP. Automated light-induced synthesis of Zr-radiolabeled antibodies for immuno-positron emission tomography. Scientific Reports. 12: 668. PMID 35027637 DOI: 10.1038/s41598-021-04626-5  0.713
2022 Guillou A, Nisli E, Klingler S, Linden A, Holland JP. Photoactivatable Fluorescent Tags for Dual-Modality Positron Emission Tomography Optical Imaging. Journal of Medicinal Chemistry. 65: 811-823. PMID 34981931 DOI: 10.1021/acs.jmedchem.1c01899  0.719
2021 Guillou A, Earley DF, Klingler S, Nisli E, Nüesch LJ, Fay R, Holland JP. The Influence of a Polyethylene Glycol Linker on the Metabolism and Pharmacokinetics of a Zr-Radiolabeled Antibody. Bioconjugate Chemistry. PMID 34056896 DOI: 10.1021/acs.bioconjchem.1c00172  0.719
2021 Fay R, Holland JP. Tuning tetrazole photochemistry for protein ligation and molecular imaging. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 33427351 DOI: 10.1002/chem.202100061  0.359
2020 Lamb J, d'Orchymont F, Fay R, Gribi F, Flores JE, Gut M, Klingler S, Pires P, Bühler J, Behmaneshfar S, Guillou A, Earley DF, Holland JP. Expanding the Chemistry Palette for Radiotracer Synthesis. Chimia. 74: 946-952. PMID 33357287 DOI: 10.2533/chimia.2020.946  0.697
2020 Guillou A, Earley DF, Patra M, Holland JP. Light-induced synthesis of protein conjugates and its application in photoradiosynthesis of Zr-radiolabeled monoclonal antibodies. Nature Protocols. PMID 33028982 DOI: 10.1038/s41596-020-0386-5  0.545
2020 Martin S, Maus S, Stemler T, Rosar F, Khreish F, Holland JP, Ezziddin S, Bartholomä MD. Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates. Molecular Imaging and Biology. PMID 32856224 DOI: 10.1007/S11307-020-01530-8  0.355
2020 Guillou A, Earley D, Holland JP. Light-activated protein-conjugation and 89Zr-radiolabelling with water-soluble desferrioxamine derivatives. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 32286712 DOI: 10.1002/Chem.202001755  0.421
2020 Fay R, Linden A, Holland JP. PhotoTag: Photoactivatable Fluorophores for Protein Labeling. Organic Letters. PMID 32283028 DOI: 10.1021/Acs.Orglett.0C00957  0.33
2020 Varlow C, Murrell E, Holland JP, Kassenbrock A, Shannon W, Liang SH, Vasdev N, Stephenson NA. Revisiting the Radiosynthesis of [F]FPEB and Preliminary PET Imaging in a Mouse Model of Alzheimer's Disease. Molecules (Basel, Switzerland). 25. PMID 32098347 DOI: 10.3390/Molecules25040982  0.322
2020 Holland JP. Predicting the Thermodynamic Stability of Zirconium Radiotracers. Inorganic Chemistry. PMID 31940188 DOI: 10.1021/Acs.Inorgchem.9B03515  0.361
2020 Klingler S, Fay R, Holland JP. Light-induced radiosynthesis of ZrDFO-azepin-onartuzumab for imaging the hepatocyte growth factor receptor. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31924725 DOI: 10.2967/Jnumed.119.237180  0.737
2020 Holland JP, Gut M, Klingler S, Fay R, Guillou A. Frontispiece: Photochemical Reactions in the Synthesis of Protein–Drug Conjugates Chemistry – a European Journal. 26. DOI: 10.1002/Chem.202080162  0.692
2019 Lamb J, Fischer E, Rosillo-Lopez M, Salzmann CG, Holland JP. Multi-functionalised graphene nanoflakes as tumour-targeting theranostic drug-delivery vehicles. Chemical Science. 10: 8880-8888. PMID 32874485 DOI: 10.1039/C9Sc03736E  0.355
2019 Holland JP, Gut M, Klingler S, Fay R, Guillou A. Photochemical reactions in the synthesis of protein-drug conjugates. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 31599057 DOI: 10.1002/Chem.201904059  0.725
2019 Frei A, Fischer E, Childs BC, Holland JP, Alberto R. Two is better than one: difunctional high-affinity PSMA probes based on a [CpM(CO)] (M = Re/Tc) scaffold. Dalton Transactions (Cambridge, England : 2003). PMID 31549121 DOI: 10.1039/C9Dt02506E  0.379
2019 Gut M, Holland JP. Synthesis and Photochemical Studies on Gallium and Indium Complexes of DTPA-PEG-ArN for Radiolabeling Antibodies. Inorganic Chemistry. 58: 12302-12310. PMID 31522510 DOI: 10.1021/Acs.Inorgchem.9B01802  0.379
2019 Brown CJM, Gotsbacher MP, Holland JP, Codd R. endo-Hydroxamic Acid Monomers for the Assembly of a Suite of Non-native Dimeric Macrocyclic Siderophores Using Metal-Templated Synthesis. Inorganic Chemistry. PMID 31185545 DOI: 10.1021/Acs.Inorgchem.9B00878  0.315
2019 Fay R, Gut M, Holland JP. Photoradiosynthesis of 68Ga-labelled HBED-CC-azepin-MetMAb for immuno-PET of c-MET receptors. Bioconjugate Chemistry. PMID 31117346 DOI: 10.1021/Acs.Bioconjchem.9B00342  0.343
2019 Patra M, Klingler S, Eichenberger LS, Holland JP. Simultaneous Photoradiochemical Labeling of Antibodies for Immuno-Positron Emission Tomography. Iscience. 13: 416-431. PMID 30903963 DOI: 10.1016/J.Isci.2019.03.004  0.778
2019 Fay R, Holland JP. The impact of emerging bioconjugation chemistries on radiopharmaceuticals. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30902878 DOI: 10.2967/Jnumed.118.220806  0.36
2019 Eichenberger LS, Patra M, Holland JP. Photoactive chelates for radiolabelling proteins. Chemical Communications (Cambridge, England). PMID 30604798 DOI: 10.1039/C8Cc09660K  0.558
2019 Bartholomä M, Martin S, Läppchen T, Holland J, Ezziddin S. Preclinical evaluation of 64Cu-labeled monomeric and trimeric (RGDfK) conjugates based on a novel chelating platform Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30238-0  0.308
2019 Patra M, Eichenberger LS, Fischer G, Holland JP. Frontispiece: Photochemical Conjugation and One-Pot Radiolabelling of Antibodies for Immuno-PET Angewandte Chemie International Edition. 58. DOI: 10.1002/Anie.201980761  0.559
2019 Patra M, Eichenberger LS, Fischer G, Holland JP. Frontispiz: Photochemische Konjugation und Eintopfradiomarkierung von Antikörpern für Immun-PET Angewandte Chemie. 131. DOI: 10.1002/Ange.201980761  0.501
2019 Patra M, Eichenberger LS, Fischer G, Holland JP. Photochemische Konjugation und Eintopfradiomarkierung von Antikörpern für Immun-PET Angewandte Chemie. 131: 1946-1951. DOI: 10.1002/Ange.201813287  0.528
2018 Patra M, Eichenberger LS, Fischer G, Holland JP. Photochemical Conjugation and One-Pot Radiolabelling of Antibodies for Immuno-PET. Angewandte Chemie (International Ed. in English). PMID 30516314 DOI: 10.1002/Anie.201813287  0.607
2018 Weinmann C, Holland JP, Läppchen T, Scherer H, Maus S, Stemler T, Bohnenberger H, Ezziddin S, Kurz P, Bartholomä MD. Optimized synthesis and indium complex formation with the bifunctional chelator NODIA-Me. Organic & Biomolecular Chemistry. PMID 30276385 DOI: 10.1039/C8Ob01981A  0.349
2018 Holland JP. Chemical kinetics of radiolabelling reactions. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 29956853 DOI: 10.1002/Chem.201803261  0.31
2018 Läppchen T, Kiefer Y, Holland JP, Bartholomä MD. In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector. Nuclear Medicine and Biology. 60: 45-54. PMID 29571066 DOI: 10.1016/J.Nucmedbio.2018.03.002  0.35
2017 Boros E, Holland JP. Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29230857 DOI: 10.1002/Jlcr.3590  0.377
2017 Gourni E, Del Pozzo L, Bartholomä M, Kiefer Y, T Meyer P, Maecke HR, Holland JP. Radiochemistry and Preclinical PET Imaging of (68)Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen. Molecular Imaging. 16: 1536012117737010. PMID 29098927 DOI: 10.1177/1536012117737010  0.314
2017 Lamb JR, Holland JP. Advanced methods for radiolabelling nanomedicines for multi-modality nuclear/MR imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29025988 DOI: 10.2967/Jnumed.116.187419  0.321
2017 Schmidtke A, Läppchen T, Weinmann C, Bier-Schorr L, Keller M, Kiefer Y, Holland JP, Bartholomä MD. Gallium Complexation, Stability, and Bioconjugation of 1,4,7-Triazacyclononane Derived Chelators with Azaheterocyclic Arms. Inorganic Chemistry. PMID 28742337 DOI: 10.1021/Acs.Inorgchem.7B01129  0.365
2016 Holland JP. The Role of Molecular Imaging in Personalised Healthcare. Chimia. 70: 787-795. PMID 28661339 DOI: 10.2533/Chimia.2016.787  0.326
2016 Boros E, Holland JP, Kenton N, Rotile N, Caravan P. Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of (89)Zirconium for Positron Emission Tomography (PET) Imaging. Chempluschem. 81: 274-281. PMID 27630807 DOI: 10.1002/Cplu.201600003  0.363
2015 Boros E, Bowen AM, Josephson L, Vasdev N, Holland JP. Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles. Chemical Science. 6: 225-236. PMID 28553472 DOI: 10.1039/C4Sc02778G  0.337
2015 Liang SH, Holland JP, Stephenson NA, Kassenbrock A, Rotstein BH, Daignault CP, Lewis R, Collier L, Hooker JM, Vasdev N. PET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer's disease and nonhuman primates. Acs Chemical Neuroscience. 6: 535-41. PMID 25776827 DOI: 10.1021/Acschemneuro.5B00055  0.314
2015 Hill DE, Holland JP. Computational studies on hypervalent iodonium(III) compounds as activated precursors for 18F radiofluorination of electron-rich arenes Computational and Theoretical Chemistry. 1066: 34-46. DOI: 10.1016/J.Comptc.2015.05.012  0.355
2014 Pandit-Taskar N, O'Donoghue JA, Beylergil V, Lyashchenko S, Ruan S, Solomon SB, Durack JC, Carrasquillo JA, Lefkowitz RA, Gonen M, Lewis JS, Holland JP, Cheal SM, Reuter VE, Osborne JR, et al. ⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2093-105. PMID 25143071 DOI: 10.1007/S00259-014-2830-7  0.498
2014 Holland JP, Vasdev N. Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design. Dalton Transactions (Cambridge, England : 2003). 43: 9872-84. PMID 24722728 DOI: 10.1039/C4Dt00733F  0.377
2014 Holland JP, Liang SH, Rotstein BH, Collier TL, Stephenson NA, Greguric I, Vasdev N. Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 323-31. PMID 24327420 DOI: 10.1002/Jlcr.3158  0.32
2014 Boros E, Rybak-Akimova E, Holland JP, Rietz T, Rotile N, Blasi F, Day H, Latifi R, Caravan P. Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling. Molecular Pharmaceutics. 11: 617-29. PMID 24294970 DOI: 10.1021/Mp400686Z  0.384
2013 Pandit-Taskar N, Carrasquillo JA, O' Donoghue JA, Humm J, Lyashchenko SK, Haupt EC, Bander NH, Tagawa ST, Holland JP, Smith-Jones PM, Lewis JS, Solomon SB, Scher HI, Larson SM. Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 31. PMID 28136972 DOI: 10.1200/Jco.2013.31.6_Suppl.31  0.494
2013 Janjigian YY, Viola-Villegas N, Holland JP, Divilov V, Carlin SD, Gomes-DaGama EM, Chiosis G, Carbonetti G, de Stanchina E, Lewis JS. Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 936-43. PMID 23578997 DOI: 10.2967/Jnumed.112.110239  0.472
2013 Holland JP, Kang A, Cohrs S, Selivanova SV, Milicevic Sephton S, Betzel T, Frey D, Wieser M, Jaussi R, Kammerer RA, Schibli R, Fischer E. Synthesis and evaluation of biphenyl compounds as kinesin spindle protein inhibitors. Chemistry & Biodiversity. 10: 538-55. PMID 23576341 DOI: 10.1002/Cbdv.201200400  0.324
2013 Holland JP, Jones MW, Cohrs S, Schibli R, Fischer E. Fluorinated quinazolinones as potential radiotracers for imaging kinesin spindle protein expression. Bioorganic & Medicinal Chemistry. 21: 496-507. PMID 23245569 DOI: 10.1016/J.Bmc.2012.11.013  0.376
2013 Evans MJ, Holland JP, Rice SL, Doran MG, Cheal SM, Campos C, Carlin SD, Mellinghoff IK, Sawyers CL, Lewis JS. Imaging tumor burden in the brain with 89Zr-transferrin. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 90-5. PMID 23236019 DOI: 10.2967/Jnumed.112.109777  0.443
2013 Zeglis BM, Holland JP, Lebedev AY, Cantorias MV, Lewis JS. Radiopharmaceuticals for imaging in oncology with special emphasis on positron-emitting agents Nuclear Oncology: Pathophysiology and Clinical Applications. 35-78. DOI: 10.1007/978-0-387-48894-3_3  0.67
2012 Holland JP, Evans MJ, Rice SL, Wongvipat J, Sawyers CL, Lewis JS. Annotating MYC status with 89Zr-transferrin imaging. Nature Medicine. 18: 1586-91. PMID 23001181 DOI: 10.1038/Nm.2935  0.493
2012 Holland JP, Cumming P, Vasdev N. PET of signal transduction pathways in cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1333-6. PMID 22879078 DOI: 10.2967/Jnumed.112.105387  0.344
2012 Ulmert D, Evans MJ, Holland JP, Rice SL, Wongvipat J, Pettersson K, Abrahamsson PA, Scardino PT, Larson SM, Lilja H, Lewis JS, Sawyers CL. Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. Cancer Discovery. 2: 320-7. PMID 22576209 DOI: 10.1158/2159-8290.Cd-11-0316  0.468
2012 Mu L, Fischer CR, Holland JP, Becaud J, Schubiger PA, Schibli R, Ametamey SM, Graham K, Stellfeld T, Dinkelborg LM, Lehmann L. 18F-radiolabeling of aromatic compounds using triarylsulfonium salts European Journal of Organic Chemistry. 889-892. DOI: 10.1002/Ejoc.201101730  0.324
2011 Janjigian YY, Villegas NT, Holland JP, Shah MA, Divilov V, Kelsen DP, Lewis JS. Positron emission tomography (PET) with (89)Zr-labeled trastuzumab ((89)Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 35. PMID 27985695 DOI: 10.1200/Jco.2011.29.4_Suppl.35  0.503
2011 Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova A, Bander NH, Lewis JS, Grimm J. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1608-15. PMID 21908391 DOI: 10.2967/Jnumed.111.092098  0.507
2011 Holland JP, Normand G, Ruggiero A, Lewis JS, Grimm J. Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions. Molecular Imaging. 10: 177-86, 1-3. PMID 21496448 DOI: 10.2310/7290.2010.00047S  0.538
2011 Heneweer C, Holland JP, Divilov V, Carlin S, Lewis JS. Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 625-633. PMID 21421727 DOI: 10.2967/Jnumed.110.083998  0.481
2010 Ruggiero A, Villa CH, Holland JP, Sprinkle SR, May C, Lewis JS, Scheinberg DA, McDevitt MR. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes. International Journal of Nanomedicine. 5: 783-802. PMID 21042424 DOI: 10.2147/Ijn.S13300  0.516
2010 Matas I, Whittell GR, Partridge BM, Holland JP, Haddow MF, Green JC, Manners I. Synthesis, electronic structure, and reactivity of strained nickel-, palladium-, and platinum-bridged [1]ferrocenophanes. Journal of the American Chemical Society. 132: 13279-89. PMID 20812743 DOI: 10.1021/Ja103367E  0.459
2010 Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1293-300. PMID 20660376 DOI: 10.2967/Jnumed.110.076174  0.492
2010 Ruggiero A, Holland JP, Lewis JS, Grimm J. Cerenkov luminescence imaging of medical isotopes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1123-30. PMID 20554722 DOI: 10.2967/Jnumed.110.076521  0.505
2010 Lebedev AY, Holland JP, Lewis JS. Clickable bifunctional radiometal chelates for peptide labeling. Chemical Communications (Cambridge, England). 46: 1706-8. PMID 20177623 DOI: 10.1039/B924784J  0.459
2010 Holland JP, Williamson MJ, Lewis JS. Unconventional nuclides for radiopharmaceuticals. Molecular Imaging. 9: 1-20. PMID 20128994 DOI: 10.2310/7290.2010.00008  0.513
2010 Holland JP, Caldas-Lopes E, Divilov V, Longo VA, Taldone T, Zatorska D, Chiosis G, Lewis JS. Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab. Plos One. 5: e8859. PMID 20111600 DOI: 10.1371/Journal.Pone.0008859  0.47
2010 Woollard-Shore JG, Holland JP, Jones MW, Dilworth JR. Nitrite reduction by copper complexes. Dalton Transactions (Cambridge, England : 2003). 39: 1576-85. PMID 20104320 DOI: 10.1039/B913463H  0.547
2010 Holland JP, Green JC. Evaluation of exchange-correlation functionals for time-dependent density functional theory calculations on metal complexes. Journal of Computational Chemistry. 31: 1008-14. PMID 19777596 DOI: 10.1002/Jcc.21385  0.489
2010 Heneweer C, Holland J, Divilov V, Carlin S, Lewis J. Quantifizierung von EPR-Effekten 89Zr-Albumin in drei Prostatakarzinommodellen in vivo RöFo - Fortschritte Auf Dem Gebiet Der RöNtgenstrahlen Und Der Bildgebenden Verfahren. 182. DOI: 10.1055/s-0030-1268308  0.393
2010 Holland JP, Lewis JS. 89Zr-chemistry in the design of novel radiotracers for immunoPET Nuclear Medicine and Biology. 37: 690. DOI: 10.1016/J.Nucmedbio.2010.04.068  0.446
2010 Christlieb M, Holland JP, Dilworth JR. Investigation of the UV-Vis absorption of bis(N-methylthiosemicarbazonato) zinc Zn[ATSM] Inorganica Chimica Acta. 363: 1133-1139. DOI: 10.1016/J.Ica.2009.10.006  0.498
2010 Holland JP, Fisher V, Hickin JA, Peach JM. Pyrene-functionalised copper complexes as potential dual-modality imaging agents European Journal of Inorganic Chemistry. 48-58. DOI: 10.1002/Ejic.200900823  0.407
2009 Holland JP, Ferdani R, Anderson CJ, Lewis JS. Copper-64 Radiopharmaceuticals for Oncologic Imaging. Pet Clinics. 4: 49-67. PMID 27156895 DOI: 10.1016/J.Cpet.2009.04.013  0.523
2009 Bell F, Holland J, Green JC, Gagné MR. Computational Studies on the Pt(II)-Catalyzed Cycloisomerization of 1,6-dienes into Bicyclopropanes: A Mechanistic Quandary Evaluated by DFT. Organometallics. 28: 2038-2045. PMID 20161262 DOI: 10.1021/Om800760X  0.475
2009 Holland JP, Sheh Y, Lewis JS. Standardized methods for the production of high specific-activity zirconium-89. Nuclear Medicine and Biology. 36: 729-39. PMID 19720285 DOI: 10.1016/J.Nucmedbio.2009.05.007  0.553
2009 Barnard PJ, Holland JP, Bayly SR, Wadas TJ, Anderson CJ, Dilworth JR. Macrocyclic diamide ligand systems: potential chelators for 64Cu- and 68Ga-based positron emission tomography imaging agents. Inorganic Chemistry. 48: 7117-26. PMID 19588930 DOI: 10.1021/Ic900307F  0.584
2009 Masson G, Herbert DE, Whittell GR, Holland JP, Lough AJ, Green JC, Manners I. Synthesis and reactivity of a strained silicon-bridged [1]ferrocenophanium ion. Angewandte Chemie (International Ed. in English). 48: 4961-4. PMID 19492392 DOI: 10.1002/Anie.200901213  0.443
2009 Holland JP, Giansiracusa JH, Bell SG, Wong LL, Dilworth JR. In vitro kinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals. Physics in Medicine and Biology. 54: 2103-19. PMID 19287086 DOI: 10.1088/0031-9155/54/7/017  0.553
2009 Choi JC, Hausner SH, Gagnon MKJ, Kukis DL, Holland JP, Lewis JS, Lin C, Johnson MD, Sutcliffe JL. Abstract A227: Positron emission tomographic (PET) imaging of activated matriptase, a marker for cancer progression Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A227  0.515
2009 Holland JP, Caldas‐Lopes E, Divilov V, Longo VA, Taldone T, Zatorska D, Chiosis G, Lewis JS. Abstract A226: ImmunoPET with 89Zr‐DFO‐trastuzumab: Monitoring the pharmacodynamic effects on HER2/neu expression by Hsp90 inhibition in vivo Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A226  0.511
2009 Holland JP, Jones MW, Bonnitcha PD, Lewis JS, Dilworth JR. Functionalised copper-64 complexes as precursors of potential PET imaging agents for neurodegenerative disorders New Journal of Chemistry. 33: 1845-1852. DOI: 10.1039/B902895A  0.657
2009 Holland JP, Barnard PJ, Bayly SR, Dilworth JR, Green JC. Electronic absorption spectroscopy and time-dependent density functional theory calculations on the nickel(II) complex of 1,4-bis(pyrrol-2-ylmethyleneamino)butane Inorganica Chimica Acta. 362: 402-406. DOI: 10.1016/J.Ica.2008.04.031  0.597
2009 Holland JP, Ferdani R, Anderson CJ, Lewis JS. Copper-64 Radiopharmaceuticals for Oncologic Imaging Pet Clinics. 4: 49-67. DOI: 10.1016/j.cpet.2009.04.013  0.431
2009 Holland JP, Fisher V, Hickin JA, Peach JM. Pyrene-Functionalised Copper Complexes as Potential Dual-Modality Imaging Agents (Eur. J. Inorg. Chem. 1/2010) European Journal of Inorganic Chemistry. 2010: 3-3. DOI: 10.1002/Ejic.200990105  0.376
2008 Holland JP, Barnard PJ, Dilworth JR, Watkin DJ. (2-Hydroxy-phenyl-imido-κN)(methano-lato-κO)[2-(2-oxidobenzyl-ideneamino)phenolato-κO,N,O'](triphenyl-phosphine-κP)rhenium(V). Acta Crystallographica. Section E, Structure Reports Online. 64: m773. PMID 21202465 DOI: 10.1107/S1600536808010684;  0.499
2008 Bayly SR, King RC, Honess DJ, Barnard PJ, Betts HM, Holland JP, Hueting R, Bonnitcha PD, Dilworth JR, Aigbirhio FI, Christlieb M. In vitro and in vivo evaluations of a hydrophilic 64Cu-bis(thiosemicarbazonato)-glucose conjugate for hypoxia imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1862-8. PMID 18927340 DOI: 10.2967/Jnumed.108.054015  0.519
2008 Betts HM, Barnard PJ, Bayly SR, Dilworth JR, Gee AD, Holland JP. Controlled axial coordination: solid-phase synthesis and purification of metallo-radiopharmaceuticals. Angewandte Chemie (International Ed. in English). 47: 8416-9. PMID 18773404 DOI: 10.1002/Anie.200801936  0.49
2008 Holland JP, Barnard PJ, Collison D, Dilworth JR, Edge R, Green JC, McInnes EJ. Spectroelectrochemical and computational studies on the mechanism of hypoxia selectivity of copper radiopharmaceuticals. Chemistry (Weinheim An Der Bergstrasse, Germany). 14: 5890-907. PMID 18494010 DOI: 10.1002/Chem.200800539  0.628
2008 Khalimon AY, Holland JP, Kowalczyk RM, McInnes EJ, Green JC, Mountford P, Nikonov GI. Synthesis and molecular and electronic structure of an unusual paramagnetic borohydride complex Mo(NAr)2(PMe3)2(eta2-BH4). Inorganic Chemistry. 47: 999-1006. PMID 18173264 DOI: 10.1021/Ic701826V  0.492
2008 Holland JP, Barnard PJ, Collison D, Dilworth JR, Edge R, Green JC, Heslop JM, McInnes EJL, Salzmann CG, Thompson AL. Synthesis, X-ray crystallography, spectroelectrochemistry and computational studies on potential copper-based radiopharmaceuticals European Journal of Inorganic Chemistry. 3549-3560. DOI: 10.1002/Ejic.200800413  0.648
2008 Holland JP, Barnard PJ, Bayly SR, Betts HM, Churchill GC, Dilworth JR, Edge R, Green JC, Hueting R. Synthesis, radiolabelling and confocal fluorescence microscopy of styrene-derivatised bis(thiosemicarbazonato)zinc and -copper complexes European Journal of Inorganic Chemistry. 1985-1993. DOI: 10.1002/Ejic.200701351  0.645
2007 Holland JP, Aigbirhio FI, Betts HM, Bonnitcha PD, Burke P, Christlieb M, Churchill GC, Cowley AR, Dilworth JR, Donnelly PS, Green JC, Peach JM, Vasudevan SR, Warren JE. Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: synthetic platforms toward site-specific radiopharmaceuticals. Inorganic Chemistry. 46: 465-85. PMID 17279826 DOI: 10.1021/Ic0615628  0.645
2006 Holland JP, Green JC, Dilworth JR. Probing the mechanism of hypoxia selectivity of copper bis(thiosemicarbazonato) complexes: DFT calculation of redox potentials and absolute acidities in solution. Dalton Transactions (Cambridge, England : 2003). 783-94. PMID 16437173 DOI: 10.1039/B512656H  0.625
Show low-probability matches.